14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $9.67 $11.24 Thursday, 2nd May 2024 IMTX stock ended at $10.89. This is 0.740% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 2.70% from a day low at $10.73 to a day high of $11.02.
90 days $9.67 $13.16
52 weeks $7.16 $13.16

Historical immatics biotechnologies GmbH prices

Date Open High Low Close Volume
May 02, 2024 $10.88 $11.02 $10.73 $10.89 307 316
May 01, 2024 $9.97 $11.02 $9.96 $10.81 634 323
Apr 30, 2024 $9.91 $10.24 $9.80 $9.93 229 547
Apr 29, 2024 $10.11 $10.26 $9.95 $9.98 242 475
Apr 26, 2024 $9.84 $10.05 $9.77 $10.01 290 330
Apr 25, 2024 $10.01 $10.04 $9.67 $9.78 677 893
Apr 24, 2024 $10.42 $10.54 $10.13 $10.15 151 970
Apr 23, 2024 $10.25 $10.60 $10.25 $10.42 383 921
Apr 22, 2024 $10.25 $10.41 $10.08 $10.19 200 231
Apr 19, 2024 $10.18 $10.53 $10.12 $10.21 181 063
Apr 18, 2024 $10.27 $10.70 $10.04 $10.26 432 141
Apr 17, 2024 $10.43 $10.61 $10.19 $10.23 483 475
Apr 16, 2024 $10.57 $10.57 $10.26 $10.38 213 863
Apr 15, 2024 $10.57 $10.77 $10.29 $10.40 421 678
Apr 12, 2024 $10.84 $10.93 $10.50 $10.61 263 958
Apr 11, 2024 $11.02 $11.06 $10.64 $10.84 421 844
Apr 10, 2024 $10.83 $11.24 $10.54 $11.00 281 305
Apr 09, 2024 $10.77 $11.08 $10.63 $11.04 233 209
Apr 08, 2024 $10.54 $10.80 $10.48 $10.74 256 432
Apr 05, 2024 $10.69 $10.86 $10.54 $10.58 148 366
Apr 04, 2024 $10.60 $10.85 $10.47 $10.71 381 722
Apr 03, 2024 $10.73 $10.82 $10.47 $10.54 255 042
Apr 02, 2024 $10.93 $10.93 $10.65 $10.73 318 095
Apr 01, 2024 $10.52 $11.21 $10.36 $11.05 584 668
Mar 28, 2024 $11.12 $11.22 $10.46 $10.51 1 031 061
Click to get the best stock tips daily for free!

About immatics biotechnologies GmbH

immatics biotechnologies GmbH Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its ACTengine product candidates are in Phase I ... IMTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT